Progression of Sub-Clinical Atherosclerosis
NCT00241787 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2900
Last updated 2015-12-02
Summary
To determine the rate of progression of sub-clinical cardiovascular disease as measured in carotid intimal medial thickness over a period of 8 to 10 years.
Conditions
- Atherosclerosis
- Cardiovascular Diseases
- Heart Diseases
- Carotid Artery Diseases
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
Tufts Medical Center
lead OTHER
Principal Investigators
-
Joseph F Polak, MD, MPH · Tufts Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-09-30
- Primary Completion
- 2011-08-31
- Completion
- 2011-08-31
More Related Trials
-
Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication
NCT00715273 ·Status: COMPLETED ·Phase: PHASE4
-
Eliminate Coronary Artery Disease
NCT02245087 ·Status: TERMINATED ·Phase: PHASE2
-
NHLBI Type II Coronary Intervention Study
NCT00000594 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients
NCT00853827 ·Status: COMPLETED ·Phase: PHASE3
-
The Surem TRAF3IP2 Level and Atherosclerotic Plaque Development in Human
NCT05945394 ·Status: UNKNOWN
-
Familial Atherosclerosis Treatment Study
NCT00000512 ·Status: COMPLETED ·Phase: PHASE3
-
Fluvastatin in the Therapy of Acute Coronary Syndrome
NCT00171275 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED)
NCT00421278 ·Status: COMPLETED ·Phase: PHASE2
-
Statins and Risk of Myocardial Infarction in Real Life in France
NCT00679575 ·Status: COMPLETED
-
Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome
NCT01223586 ·Status: COMPLETED
-
the Change of Cholesterol Efflux Capacity and Coronary Artery Disease in Real Clinical Practice
NCT03389529 ·Status: UNKNOWN
-
Postprandial Lipemia and Endothelial Function in ACCORD- Ancillary to ACCORD
NCT00037401 ·Status: COMPLETED
-
PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis
NCT07256197 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Notify 2: An Evaluation of the Impact of Notification of Incidental Coronary Artery Calcium on Statin Rates
NCT05394181 ·Status: WITHDRAWN ·Phase: NA
-
Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography
NCT06863545 ·Status: RECRUITING ·Phase: NA
-
The Effects of Atorvastatin in Patients With Atherosclerosis
NCT00115817 ·Status: COMPLETED ·Phase: PHASE3
-
Monocyte Activation in Preclinical Atherosclerosis
NCT02126280 ·Status: COMPLETED
-
Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome
NCT05298475 ·Status: UNKNOWN ·Phase: PHASE4
-
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
NCT00880178 ·Status: COMPLETED
-
Carotid Intima-media Thickness in Japan Statin Treatment Against Recurrent Stroke(J-STARS Echo)
NCT00361530 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Acute Statin Treatment in Patients Undergoing Percutaneous Coronary Intervention
NCT00588471 ·Status: TERMINATED ·Phase: NA
-
Inflammation and Coronary Endothelial Function
NCT02366091 ·Status: COMPLETED ·Phase: PHASE2
-
Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes
NCT02850081 ·Status: TERMINATED ·Phase: PHASE3
-
Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED)
NCT00804843 ·Status: COMPLETED ·Phase: PHASE2
-
the Change of CEM and the Prognosis of Coronary Artery Disease in Real Clinical Practice
NCT03473860 ·Status: UNKNOWN